Sökning: WFRF:(Aslam Rukhsana) > (2020) > Thrombopoietin rece...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03498naa a2200421 4500 | |
001 | oai:lup.lub.lu.se:f845d38a-c511-472a-9bff-92630ca9115c | |
003 | SwePub | |
008 | 190625s2020 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/f845d38a-c511-472a-9bff-92630ca9115c2 URI |
024 | 7 | a https://doi.org/10.1080/09537104.2019.16247092 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Kapur, Ricku University of Amsterdam,Academic Medical Center of University of Amsterdam (AMC)4 aut0 (Swepub:lu)ri1121ka |
245 | 1 0 | a Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP) |
264 | c 2019-05-30 | |
264 | 1 | b Informa UK Limited,c 2020 |
300 | a 4 s. | |
520 | a Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder in which autoantibodies and/or autoreactive T cells destroy platelets and megakaryocytes in the spleen and bone marrow, respectively. Thrombopoietin receptor agonists (TPO-RA e.g. Romiplostim and Eltrombopag) have made a substantial contribution to the treatment of patients with ITP, which are refractory to first-line treatments and approximately 30% demonstrate sustained elevated platelet counts after drug tapering. How TPO-RA induce these sustained responses is not known. We analyzed the efficacy of a murine TPO-RA in a well-established murine model of active ITP. Treatment with TPO-RA (10 ug/kg, based on pilot dose escalation experiments) significantly raised the platelet counts in ITP-mice. Immunomodulation was assessed by measuring serum IgG anti-platelet antibody levels; TPO-RA-treated mice had significantly reduced IgG anti-platelet antibodies despite the increasing platelet counts. These results suggest that TPO-RA is not only an efficacious therapy but also reduces anti-platelet humoral immunity in ITP. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Hematologi0 (SwePub)302022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Hematology0 (SwePub)302022 hsv//eng |
653 | a Immune thrombocytopenia (ITP) | |
653 | a immunomodulation | |
653 | a platelet antibodies | |
653 | a platelet counts | |
653 | a thrombopoietin receptor agonist (TPO-RA) | |
700 | 1 | a Aslam, Rukhsanau Saint Michael's Hospital4 aut |
700 | 1 | a Speck, Edwin R.u Saint Michael's Hospital4 aut |
700 | 1 | a Rebetz, Johan M.u Lund University,Lunds universitet,Trombocyt immunologi,Forskargrupper vid Lunds universitet,Platelet Immunology,Lund University Research Groups4 aut0 (Swepub:lu)wbla-jre |
700 | 1 | a Semple, John W.u Lund University,Lunds universitet,Trombocyt immunologi,Forskargrupper vid Lunds universitet,Platelet Immunology,Lund University Research Groups,University of Toronto,Saint Michael's Hospital4 aut0 (Swepub:lu)jo0201se |
710 | 2 | a University of Amsterdamb Academic Medical Center of University of Amsterdam (AMC)4 org |
773 | 0 | t Plateletsd : Informa UK Limitedg 31:3, s. 399-402q 31:3<399-402x 0953-7104x 1369-1635 |
856 | 4 | u http://dx.doi.org/10.1080/09537104.2019.1624709x freey FULLTEXT |
856 | 4 | u https://www.tandfonline.com/doi/pdf/10.1080/09537104.2019.1624709?needAccess=true |
856 | 4 8 | u https://lup.lub.lu.se/record/f845d38a-c511-472a-9bff-92630ca9115c |
856 | 4 8 | u https://doi.org/10.1080/09537104.2019.1624709 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy